Furthermore, cancer gene therapy using HPV pseudovirions carrying HSV-tk was capable of specifically targeting the ovarian tumors, resulting potent therapeutic antitumor effects against ovarian tumors. This evidence concerns the gene TKT and ovarian neoplasm.